Publication | Open Access
Phare Trial Results Comparing 6 to 12 Months of Trastuzumab in Adjuvant Early Breast Cancer
16
Citations
0
References
2012
Year
Phare Trial ResultsBreast OncologyOncologyClinical TrialsBreast CancerCancer TreatmentMedicineRadiation OncologyHealth Sciences
No additional data available for this publication yet. Check back later!